Stable renal function and benign course in azotemic diabetics treated with erythropoietin for one year.
Brown
C D
CD
Department of Medicine, State University of New York, Brooklyn.
Friedman
E A
EA
D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy*; D001794:Blood Pressure / Q000187:drug effects; D001809:Blood Viscosity / Q000187:drug effects; D003404:Creatinine / Q000097:blood; D003928:Diabetic Nephropathies / Q000097:blood / Q000150:complications*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use; D014511:Uremia / Q000097:blood / Q000150:complications*
D011994:Recombinant Proteins; D004921:Erythropoietin; D003404:Creatinine